PPA
FMTX

Parametric Portfolio Associates’s Forma Therapeutics Holdings, Inc. Common Stock FMTX Stock Holding History

Parametric Portfolio Associates’s Portfolio FMTX Stock Details FMTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$96K Sell
10,291
-117,340
-92% -$1.25M ﹤0.01% 3570
2021
Q4 		$1.81M Buy
127,631
+27,855
+28% +$482K ﹤0.01% 2491
2021
Q3 		$2.31M Buy
99,776
+8,289
+9% +$196K ﹤0.01% 2359
2021
Q2 		$2.28M Buy
91,487
+38,137
+71% +$1.02M ﹤0.01% 2359
2021
Q1 		$1.5M Buy
53,350
+20,636
+63% +$745K ﹤0.01% 2961
2020
Q4 		$1.14M Buy
32,714
+9,269
+40% +$404K ﹤0.01% 2976
2020
Q3 		$1.17M Buy
+23,445
New +$948K ﹤0.01% 2823

Other funds holding FMTX

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.22B AUM 242.83% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Parametric Portfolio Associates's FMTX Position: Q1 2022 in Review

Parametric Portfolio Associates reduced its Forma Therapeutics Holdings, Inc. Common Stock (FMTX) stake by 92% in Q1 2022, selling an estimated $1.25M and leaving 10,291 shares worth $96K. The position accounts for ﹤0.01% of the portfolio, ranked #3570.

Parametric Portfolio Associates first reported a position in FMTX in Q3 2020 and has held it in 7 quarters since. The position peaked at $2.31M in Q3 2021. 98 funds tracked by Wall St. Rank hold FMTX as of Q1 2022.

  • Parametric Portfolio Associates held 10,291 shares of Forma Therapeutics Holdings, Inc. Common Stock worth $96K as of Q1 2022.
  • Parametric Portfolio Associates sold 117,340 Forma Therapeutics Holdings, Inc. Common Stock shares in Q1 2022, an estimated $1.25M.
  • Forma Therapeutics Holdings, Inc. Common Stock made up ﹤0.01% of Parametric Portfolio Associates's portfolio in Q1 2022, its #3570 holding.
  • Parametric Portfolio Associates first reported a position in Forma Therapeutics Holdings, Inc. Common Stock in Q3 2020 and has held it in 7 quarters since.
  • Parametric Portfolio Associates's Forma Therapeutics Holdings, Inc. Common Stock position peaked at $2.31M in Q3 2021.
  • 98 funds tracked by Wall St. Rank held Forma Therapeutics Holdings, Inc. Common Stock as of Q1 2022.

Based on Parametric Portfolio Associates's 13F filing for Q1 2022, filed 16 May 2022.